A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients
Clinical trial NCT02566031 · COMPLETED
Trial details
- NCT number
- NCT02566031
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-23
- Primary completion
- 2018-06-04
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.